Neurocrine Biosciences, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of NBIX for the last quarter is 590.20 M USD, and it's 14.54% higher compared to the previous quarter. The net income of Q2 24 is 65.00 M USD.